The GNOM ETF is a fund that invests in companies focused on gene editing and genomic research. It aims to provide exposure to innovative technology in the healthcare sector. The fund holds stocks of companies involved in genetic testing, gene therapy, and other related technologies. The goal of the GNOM ETF is to capture potential growth in the genomics industry.

Global X Genomics & Biotechnology ETF



The Diagnostics & Research industry is responsible for developing and providing medical tests that help diagnose diseases and conditions. They work to research and create new tests, analyze data, and find treatments and cures for diseases. This industry plays a crucial role in the healthcare system by providing accurate and reliable tests that help doctors make appropriate treatment decisions.

Natera Inc



The Biotechnology industry involves the use of living organisms, cells or biological processes to develop and manufacture new products that improve healthcare, agriculture, and industry. It includes genetically modified crop production, new drug development, and advanced diagnostics. Many biotech products are the result of genetic engineering, using cutting-edge technology to manipulate DNA to create new products, such as synthetic insulin or cancer-fighting drugs.

Sarepta Therapeutics Inc

Alnylam Pharmaceuticals Inc

Ultragenyx

Crispr Therapeutics AG

Genscript Biotech Corp

Bio-Techne Corp

Agilent Technologies Inc

Qiagen NV

Biomarin Pharmaceutical Inc

Myriad Genetics Inc

Arrowhead Pharmaceuticals Inc

Vertex Pharmaceuticals Inc



The Health Information Services industry manages and organizes health data and medical records. They ensure that patient information is accurate, secure, and accessible to healthcare providers when needed. They also use technology to improve patient care, research, and healthcare operations.

10x Genomics

Veracyte Inc

BioNTech SE

Rocket Pharmaceuticals Inc

Beam Therapeutics Inc



The Drug Manufacturers-General industry is a group of companies that produce and sell medication to treat a wide range of health conditions. These companies invest heavily in research and development to create new drugs and ensure safety for consumers. They are regulated by government agencies to ensure quality and efficacy of their products.

Gilead Sciences Inc

Illumina Inc

Intellia Therapeutics Inc

Moderna Inc

Caredx Inc

Takara Bio Inc

Regenxbio Inc

Fulgent Genetics Inc

Editas Medicine Inc

Stoke Therapeutics Inc



The Medical Devices industry creates equipment and instruments that are used by medical professionals to diagnose and treat patients. Examples of medical devices include surgical instruments, imaging machines like MRI and CT scanners, and implantable devices like pacemakers and artificial joints. This industry is highly regulated and innovates new technologies to improve healthcare outcomes.

Pacific Biosciences of California



The Medical Instruments & Supplies industry focuses on creating and distributing tools, equipment, and materials necessary for medical purposes. This includes everything from surgical instruments to diagnostic devices and protective gear. These products are used by healthcare professionals to provide care to patients.

Bionano Genomics Inc

Uniqure NV

Allogene Therapeutics Inc

Verve Therapeutics Inc

Caribou Biosciences Inc

Bluebird bio Inc

Sangamo Therapeutics Inc

NanoString Technologies Inc

Invitae Corp

GNOM - (Global X Genomics & Biotechnology ETF) detailed list of complete holdings. Updated daily.

All 39 GNOM Holdings

Rank	Ticker	Company	Weight	Country	Market Cap	Industry

1	NTRA	Natera Inc	11.42%	United States	$5.12b	Diagnostics & Research
2	SRPT	Sarepta Therapeutics Inc	6.75%	United States	$9.54b	Biotechnology
3	ALNY	Alnylam Pharmaceuticals Inc	5.92%	United States	$24b	Biotechnology
4	RARE	Ultragenyx	5.02%	United States	$3.03b	Biotechnology
5	CRSP	Crispr Therapeutics AG	4.78%	United States	$4.51b	Biotechnology
6	1548	Genscript Biotech Corp	4.69%	Hong Kong		Biotechnology
7	TECH	Bio-Techne Corp	4.64%	United States	$13.12b	Biotechnology
8	A	Agilent Technologies Inc	4.61%	United States	$36b	Diagnostics & Research
9	QGEN	Qiagen NV	4.53%	United States	$10.66b	Diagnostics & Research
10	BMRN	Biomarin Pharmaceutical Inc	4.37%	United States	$16.40b	Biotechnology
11	MYGN	Myriad Genetics Inc	3.91%	United States	$1.82b	Diagnostics & Research
12	ARWR	Arrowhead Pharmaceuticals Inc	3.88%	United States	$3.74b	Biotechnology
13	VRTX	Vertex Pharmaceuticals Inc	3.67%	United States	$91b	Biotechnology
14	TXG	10x Genomics	3.42%	United States	$6.12b	Health Information Services
15	VCYT	Veracyte Inc	3.16%	United States	$1.98b	Biotechnology
16	BNTX	BioNTech SE	2.87%	United States	$26b	Biotechnology
17	RCKT	Rocket Pharmaceuticals Inc	2.72%	United States	$1.43b	Biotechnology
18	BEAM	Beam Therapeutics Inc	2.41%	United States	$2.23b	Biotechnology
19	GILD	Gilead Sciences Inc	2.37%	United States	$95b	Drug Manufacturers-General
20	ILMN	Illumina Inc	2.15%	United States	$30b	Diagnostics & Research
21	NTLA	Intellia Therapeutics Inc	2.08%	United States	$3.73b	Biotechnology
22	MRNA	Moderna Inc	2.04%	United States	$45b	Biotechnology
23	CDNA	Caredx Inc	1.67%	United States	$585.59m	Diagnostics & Research
24	4974	Takara Bio Inc	1.06%	Japan		Biotechnology
25	RGNX	Regenxbio Inc	0.94%	United States	$825.81m	Biotechnology
26	FLGT	Fulgent Genetics Inc	0.84%	United States	$1.15b	Diagnostics & Research
27	EDIT	Editas Medicine Inc	0.66%	United States	$605.56m	Biotechnology
28	STOK	Stoke Therapeutics Inc	0.6%	United States	$293.14m	Biotechnology
29	PACB	Pacific Biosciences of California	0.57%	United States	$3.26b	Medical Devices
30	BNGO	Bionano Genomics Inc	0.4%	United States	$179.98m	Medical Instruments & Supplies
31	QURE	Uniqure NV	0.38%	United States	$487.21m	Biotechnology
31	ALLO	Allogene Therapeutics Inc	0.38%	United States	$716.71m	Biotechnology
33	VERV	Verve Therapeutics Inc	0.36%	United States	$1.27b	Biotechnology
34	TSVT	2	0.28%	United States	$296.25m	Biotechnology
35	CRBU	Caribou Biosciences Inc	0.17%	United States	$440.74m	Biotechnology
36	BLUE	Bluebird bio Inc	0.15%	United States	$404.49m	Biotechnology
37	SGMO	Sangamo Therapeutics Inc	0.1%	United States	$222.40m	Biotechnology
38	NSTG	NanoString Technologies Inc	0.02%	United States	$222.73m	Medical Instruments & Supplies
39	NVTA	Invitae Corp	0.01%	United States	$369.85m	Diagnostics & Research